1. Home
  2. ERAS vs EBTC Comparison

ERAS vs EBTC Comparison

Compare ERAS & EBTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERAS
  • EBTC
  • Stock Information
  • Founded
  • ERAS 2018
  • EBTC 1989
  • Country
  • ERAS United States
  • EBTC United States
  • Employees
  • ERAS N/A
  • EBTC N/A
  • Industry
  • ERAS Biotechnology: Pharmaceutical Preparations
  • EBTC Major Banks
  • Sector
  • ERAS Health Care
  • EBTC Finance
  • Exchange
  • ERAS Nasdaq
  • EBTC Nasdaq
  • Market Cap
  • ERAS 396.6M
  • EBTC 446.9M
  • IPO Year
  • ERAS 2021
  • EBTC 2005
  • Fundamental
  • Price
  • ERAS $1.43
  • EBTC $38.91
  • Analyst Decision
  • ERAS Strong Buy
  • EBTC
  • Analyst Count
  • ERAS 6
  • EBTC 0
  • Target Price
  • ERAS $4.83
  • EBTC N/A
  • AVG Volume (30 Days)
  • ERAS 1.5M
  • EBTC 21.2K
  • Earning Date
  • ERAS 05-20-2025
  • EBTC 04-17-2025
  • Dividend Yield
  • ERAS N/A
  • EBTC 2.59%
  • EPS Growth
  • ERAS N/A
  • EBTC 11.95
  • EPS
  • ERAS N/A
  • EBTC 3.27
  • Revenue
  • ERAS N/A
  • EBTC $172,242,000.00
  • Revenue This Year
  • ERAS N/A
  • EBTC N/A
  • Revenue Next Year
  • ERAS N/A
  • EBTC N/A
  • P/E Ratio
  • ERAS N/A
  • EBTC $11.73
  • Revenue Growth
  • ERAS N/A
  • EBTC 7.98
  • 52 Week Low
  • ERAS $1.01
  • EBTC $22.60
  • 52 Week High
  • ERAS $3.45
  • EBTC $44.41
  • Technical
  • Relative Strength Index (RSI)
  • ERAS 52.92
  • EBTC 60.92
  • Support Level
  • ERAS $1.37
  • EBTC $38.23
  • Resistance Level
  • ERAS $1.61
  • EBTC $39.41
  • Average True Range (ATR)
  • ERAS 0.14
  • EBTC 0.90
  • MACD
  • ERAS 0.00
  • EBTC 0.45
  • Stochastic Oscillator
  • ERAS 53.09
  • EBTC 91.98

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.

About EBTC Enterprise Bancorp Inc

Enterprise Bancorp Inc is a holding company engaged in the business of gathering deposits from the general public and investing in loans and investment securities. Through the Bank and its subsidiaries, the company offers a range of commercial, residential, and consumer loan products, deposit products, and cash management services, as well as wealth management and wealth services.

Share on Social Networks: